Exscientia AI Limited
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Association of Ex Vivo Drug Response ( EVDR) and Clinical Outcome in Acute Myeloid Leukaemia (EXCYTE-2) (NCT06648512) | Exscientia AI Limited | 2024-05-13 |
| Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian Cancer (NCT06068738) | Exscientia AI Limited | 2023-04-14 |
| Study to Assess EXS21546 in Combination in Patients With Advanced Solid Tumours (NCT05920408) | Exscientia AI Limited | 2023-04-11 |
| 3-part Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EXS21546 (NCT04727138) | Exscientia AI Limited | 2020-12-08 |
Track Exscientia AI Limited automatically
Every clearance here is in the API, with alerts when new ones post.